Compare · AIRS vs PRVA
AIRS vs PRVA
Side-by-side comparison of AirSculpt Technologies Inc. (AIRS) and Privia Health Group Inc. (PRVA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AIRS and PRVA operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- PRVA is the larger of the two at $2.89B, about 28.3x AIRS ($102.0M).
- PRVA has hit the wire 2 times in the past 4 weeks while AIRS has been quiet.
- PRVA has more recent analyst coverage (25 ratings vs 8 for AIRS).
- Company
- AirSculpt Technologies Inc.
- Privia Health Group Inc.
- Price
- $1.28-9.86%
- $22.53-0.40%
- Market cap
- $102.0M
- $2.89B
- 1M return
- -44.47%
- -
- 1Y return
- -87.59%
- -
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- 2021
- News (4w)
- 0
- 2
- Recent ratings
- 8
- 25
AirSculpt Technologies Inc.
AirSculpt Technologies, Inc. focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. It offers custom body contouring using its AirSculpt procedure that removes unwanted fat in a minimally invasive procedure. The company provides fat removal procedures across treatment areas; and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips, or other areas. Its body contouring procedures also include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. As of October 5, 2021, it operated 16 centers across 13 states. The company was founded in 2012 and is headquartered in Miami Beach, Florida.
Privia Health Group Inc.
Privia Health Group, Inc. operates as a physician practice management and population health technology company in the United States. The company comprises regional medical groups, accountable care organizations, and specialty verticals. It offers technology and population health tools to enhance independent providers' workflows; management service organization that enables providers to reduce administrative work focus on their patients; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; physician-led accountable care organization, which engages patients, reduces inappropriate utilization, and enhances coordination and patient quality metrics to drive value-based care and transform the healthcare delivery system; and network for purchasers and payers. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. operates as a subsidiary of Brighton Health Group Holdings, LLC.
Latest AIRS
- Amendment: SEC Form SCHEDULE 13G/A filed by AirSculpt Technologies Inc.
- SEC Form 10-Q filed by AirSculpt Technologies Inc.
- AirSculpt Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- AirSculpt Technologies Reports Second Quarter Fiscal 2026 Results
- AirSculpt Technologies Announces Earnings Release Date, Conference Call, and Webcast for Second Quarter Fiscal 2026 Results
- AirSculpt Technologies Announces Participation in Upcoming Investor Conferences
- Director Feinstein Adam T disposed of 5,169,820 shares (SEC Form 4)
- Director Higgins Kenneth was granted 100,286 shares, increasing direct ownership by 58% to 274,066 units (SEC Form 4)
- Director Aaron Thomas J was granted 100,286 shares, increasing direct ownership by 57% to 276,866 units (SEC Form 4)
- Director Chu Caroline was granted 100,286 shares, increasing direct ownership by 57% to 277,066 units (SEC Form 4)
Latest PRVA
- Privia Health to Report Third Quarter 2026 Results on Thursday, November 5
- Amendment: SEC Form SCHEDULE 13G/A filed by Privia Health Group Inc.
- Director Ernest Opella Finley was granted 6,350 shares (SEC Form 4)
- SEC Form 3 filed by new insider Ernest Opella Finley
- Privia Health Group Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors
- SEC Form 10-Q filed by Privia Health Group Inc.
- Privia Health Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Privia Health Reports Strong Second Quarter and Year-to-Date 2026 Results
- EVP & Chief Financial Officer Mountcastle David sold $588,679 worth of shares (21,275 units at $27.67) as part of a pre-agreed trading plan, decreasing direct ownership by 11% to 164,853 units (SEC Form 4)